SEC Form 4 · accession 0000899243-16-024114
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ForArgos B.V.
10% Owner
Period of report
Jun 29, 2016
Accepted (ET)
Jul 1, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2016 | P$0 | 1,322,618 | — | A | 2,204,363 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy)F1 | $5.35 | Jun 29, 2016 | P | 991,964 | A | Jun 29, 2016 | Jun 29, 2021 | Common Stock | 991,964 | 991,964 | D |
Explanation of responses
- F1The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.